121
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Functional evaluation of various ICAM3 transcript variants in diffuse large B-Cell lymphoma

, , , , , , , , , , , , & ORCID Icon show all
Pages 2869-2878 | Received 19 Jan 2022, Accepted 16 Jun 2022, Published online: 18 Jul 2022
 

Abstract

Previous studies have identified several ICAM3 transcript variants and mainly investigated the function of the longest transcript of ICAM3 in various tumor progressions. However, the role of the other ICAM3 transcript variants remains unclear. Herein, we detected the expression of ICAM3 transcript variants 1–4 in DLBCL cells and tumor tissues, disclosed that variants 1, 3, and 4 were expressed in normal B cell lines and 3 DLBCL cell lines except SU-DHL-2 as well as tumor tissues, while variant 2 was not detected. Moreover, we found that ectopic expression of variants 1–4 enhanced cell proliferation by accelerating the cell cycle in SU-DHL2 cells in vitro. In addition, variants 1–4 overexpression showed no effects on SU-DHL2 cell apoptosis. Interestingly, the expression of variants 1, 3, and 4 promoted cell migration and EMT process while variant 2 had no effects. Collectively, the above results displayed the different roles of ICAM3 transcript variants in mediating DLBCL progression.

Disclosure statement

The authors declare no potential conflicts of interest.

Additional information

Funding

This work was supported by the Natural Science Foundation of Inner Mongolia (No. 2019MS08004, 2019MS08080), Shandong Provincial Natural Science Foundation (No. ZR2019BH003), Student Innovation Training Program of Jining Medical University (No. cx2021123).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.